Infections in IFNGR-1-deficient children

Journal of Interferon and Cytokine Research

Volumn 17, Issue 10, 1997, Pages 583-587

  Jouanguy, Emmanuelle ^a   Altare, Frédéric ^a   Lamhamedi Cherradi, Salma ^a   Casanova, Jean Laurent ^a  

^a HÔPITAL NECKER ENFANTS MALADES   (France)

Author keywords

[No Author keywords available]

Indexed keywords

BCG VACCINE; GAMMA INTERFERON;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; AUTOSOMAL RECESSIVE DISORDER; BACTERIAL VIRULENCE; CELLULAR IMMUNITY; COMBINED IMMUNODEFICIENCY; GENE EXPRESSION; GENE MUTATION; IMMUNE RESPONSE; INHERITANCE; MOUSE; MYCOBACTERIUM; NONHUMAN; OPPORTUNISTIC INFECTION; PRIORITY JOURNAL; PROGNOSIS;

EID: 0030881918     PISSN: 10799907     EISSN: None     Source Type: Journal    
DOI: 10.1089/jir.1997.17.583     Document Type: Article

References (38)

1. CASANOVA, J.-L., JOUANGUY, E., LAMHAMEDI, S., BLANCHE, S., and FISCHER, A. (1995). Immunological conditions of children with disseminated BCG infection. Lancet 346, 581.
2. CASANOVA, J.-L., BLANCHE, S., EMILE, J.-F., JOUANGUY, E., LAMHAMEDI, S., ALTARE, F., STEPHAN, J.-L., BERNAUDIN, F., BORDIGONI, P., TURCK, D., LACHAUX, A., ALBERTINI, M., BOURRILLON, A., DOMMERGUES, J.-P., POCIDALO, M.-A., LE DEIST, F., GAILLARD, J.-L., GRISCELLI, C., and FISCHER, A. (1996). Idiopathic disseminated bacillus Calmette-Guérin infection: a French national retrospective study. Pediatrics 98, 774-778.
3. EMILE, J.-F., PATEY, N., ALTARE, F., LAMHAMEDI, S., JOUANGUY, E., BOMAN, F., QUILLARD, J., LECOMTE-HOUCKE, M., VEROLA, O., MOUSNIER, J.-F., DIJOUD, F., BLANCHE, S., FISCHER, A., BROUSSE, N., and CASANOVA, J.-L. (1997). Correlation of granuloma structure with clinical outcome defines two types of idiopathic disseminated BCG infection. J. Pathol. 181, 25-30.
4. JOUANGUY, E., ALTARE, F., LAMHAMEDI, S., REVY, P., EMILE, J.-F., NEWPORT, M., LEVIN, M., BLANCHE, S., SEBOUN, E., FISCHER, A., and CASANOVA, J.-L. (1996). Interferon gamma receptor deficiency in an infant with fatal BCG infection. N. Engl. J. Med. 335, 1956-1961.
5. LEVIN, M., NEWPORT, M., D'SOUZA, S., KALABALIKIS, P., BROWN, I.N., LENICKER, H.M., AGIUS, P.V., DAVIES, E.G., THRASHER, A., KLEIN, N., and BLACKWELL, J.M. (1995). Familial disseminated atypical mycobacterial infection in childhood: a human mycobacterial susceptibility gene? Lancet 345, 79-83.
6. D'SOUZA, S., LEVIN, M., FAITH, A., YSSEL, H., BENNETT, B., LAKE, R.A., BROWN, I.N., and LAMB, J.R. (1996). Defective antigen processing associated with familial disseminated mycobacteriosis. Clin. Exp. Immunol. 103, 35-39.
7. NEWPORT, M., HUXLEY, C.M., HUSTON, S., HAWRYLOWICZ, C.M., OOSTRA, B.A., WILLIAMSON, R., and LEVIN, M. (1996). Mutation in the interferon-gamma receptor gene and susceptibility to mycobacterial infection. N. Engl. J. Med. 335, 1941-1949.
8. PIERRE-AUDIGIER, C., JOUANGUY, E., LAMHAMEDI, S., ALTARE, F., RAUZIER, J., VINCENT, V., CANIONI, D., EMILE, J.-F., FISCHER, A., BLANCHE, S., GAILLARD, J.-L., and CASANOVA, J.-L. (1997). Fatal disseminated Mycobacterium smegmatis infection in a child with inherited interferon gamma receptor deficiency. Clin. Infect. Dis. 24, 982-984.
9. ALTARE, F., JOUANGUY, E., LAMHAMEDI, S., FONDANÈCHE, M.-C., FIZAME, C., RIBIÉRRE, F., MERLIN, G., DEMBIC, Z., SCHNEIBER, R., LISOWSKA-GROSPIERRE, B., SEBOUN, E., FISCHER, A., and CASANOVA, J.L. (1997). A causative relationship between mutant IFNgR1 alleles and impaired response to IFNγ in a compound heterozygous child. Submitted for publication.
10. CASANOVA, J.-L., NEWPORT, M., FISCHER, A., and LEVIN, M. (1997). Inherited interferon gamma receptor deficiency. In: Primary Immunodeficiencies: A Molecular and Genetic Approach. H. Ochs, J. Puck, and C. Smith (eds.) New York: Oxford University Press.
11. BOULEY, D.M., KANANGAT, S., WIRE, W., and ROUSE, B.T. (1995). Characterization of herpes simplex virus type 1 infection and herpetic stromal keratitis development in IFN-gamma knock-out mice. J. Immunol. 155, 3964-3971.
12. YU, Z., MANICKAN, E., and ROUSE, B.T. (1996). Role of interferon γ in immunity to herpes simplex virus. J. Leukocyte Biol. 60, 528-532.
13. SCHIJNS, V.E.C.J., WIERDA, C.M.H., VAN HOEIJ, M., and HORZINEK, M.C. (1996). Exacerbated viral hepatitis in IFNγ receptor-deficient mice is not suppressed by IL-12. J. Immunol. 157, 815-821.
14. FIETTE, L., AUBERT, C., MÜLLER, U., HUANG, S., AGUET, M., BRAHIC, M., and BUREAU, J.-F. (1995). Theiler's virus infection of 129Sv mice that lack the interferon α/β or interferon γ receptors. J. Exp. Med. 181, 2069-2076.
15. HUANG, S., HENDRIKS, W., ALTHAGE, A., HEMMI, S., BLUETHMANN, H., KAMIJO, R., VILCEK, J., ZINKERNAGEL, R.M., and AGUET, M. (1993). Immune response in mice that lack the interferon γ receptor. Science 259, 1742-1745.
16. MÜLLER, U., STEINHOFF, U., REIS, L.F.L., HEMMI, S., PAVLOVIC, J., ZINKERNAGEL, R.M., and AGUET, M. (1994). Functional role of type I and type II interferons in antiviral defense. Science 264, 1918-1921.
17. SCHIJNS, V.E.C.J., HAAGMANS, B.L., RIJKE, E.O., HUANG, S., AGUET, M., and HORZINEK, M.C. (1994). IFNγ receptor deficient mice generate antiviral Th1 characteristic cytokine profiles but altered antibody responses. J. Immunol. 153, 2029-2037.
18. GRAHAM, M.B., DALTON, D.K., GILTINAN, D., BRACIALE, V.L., STEWART, T.A., and BRACIALE, T.J. (1993). Response to influenza infection in mice with a targeted disruption in the interferon gamma gene. J. Exp. Med. 178, 1725-1732.
19. ZHAO, Y.-X., and TARKOWSKI, A. (1995). Impact of interferon γ receptor deficiency on experimental Staphylococcus aureus septicemia and arthritis. J. Immunol. 155, 5736-5742.
20. HARTY, J.T., and BEVAN, M.J. (1995). Specific immunity to Listeria monocytogenes in the absence of IFNγ. Immunity 3, 109-117.
21. SZALAY, G., LADEL, C.H., BLUM, C., and KAUFMANN, S.H.E. (1996). IL-4 neutralization or TNFα treatment ameliorates disease by an intracellular pathogen in IFNγ receptor-deficient mice. J. Immunol. 157, 4746-4750.
22. DALTON, D.K., PITTS-MEEK, S., KESHAV, S., FIGARI, I.S., BRADLEY, A., and STEWART, T.A. (1993). Multiple defects of immune cell function in mice with disrupted interferon-γ genes. Science 259, 1739-1742.
23. KAMIJO, R., LE, J., SHAPIRO, D., HAVELL, E.A., HUANG, S., AGUET, M., BOSLAND, M., and VILCEK, J. (1993). Mice that lack the interferon-γ receptor have profoundly altered responses to infection with bacillus Calmette-Guérin and subsequent challenge with lipopolysaccharide. J. Exp. Med. 178, 1435-1440.
24. COOPER, A.M., DALTON, D.K., STEWART, T.A., GRIFFIN, J.P., RUSSELL, D.G., and ORME, I.M. (1993). Disseminated tuberculosis in interferon γ gene-disrupted mice. J. Exp. Med. 178, 2243-2247.
25. FLYNN, J.L., CHAN, J., TRIEBOLD, K.J., DALTON, D.K., STEWART, T.A., and BLOOM, B.R. (1993). An essential role for interferon γ in resistance to Mycobacterium tuberculosis infection. J. Exp. Med. 178, 2249-2254.
26. HEATH, L., CHRISP, C., HUFFNAGLE, G., LEGENDRE, M., OSAWA, Y., HURLEY, M., ENGLEBERG, C., FANTONE, J., and BRIELAND, J. (1996). Effector mechanisms responsible for γ interferon-mediated host resistance to Legionella pneumophila lung infection: the role of endogenous nitric oxide differs in susceptible and resistant murine hosts. Infect. Immun. 64, 5151-5160.
27. GARVY, B.A., EZEKOWITZ, R.A.B., and HARMSEN, A.G. (1997). Role of gamma interferon in the host immune and inflammatory responses to Pneumocystis carinii infection. Infect. Immun. 65, 373-379.
28. SCHARTON-KERSTEN, T.M., WYNN, T.A., DENKERS, E.Y., BALA, S., GRUNVALD, E., HIENY, S., GAZZINELLI, R.T., and SHER, A. (1996). In the absence of endogenous IFNγ, mice develop unimpaired IL-12 responses to Toxoplasma gondii while failing to control acute infection. J. Immunol. 157, 4045-4054.
29. DECKERT-SCHLÜTER, M., RANG, A., WEINER, D., HUANG, S., WEISTLER, O.D., HOF, H., and SCHLÜTER, D. (1996). Interferon γ receptor deficiency renders mice highly susceptible to toxoplasmosis by decreased macrophage activation. Lab. Invest. 75, 827-841.
30. + effector cells default to the Th2 pathway in IFNγ-deficient mice infected with Leishmania major. J. Exp. Med. 179, 1367.
31. + T cell response. J. Exp. Med. 181, 961-971.
32. TAYLOR, A.P., and MURRAY, H.W. (1997). Intracellular antimicrobial activity in the absence of interferon γ: effect of interleukin 12 in experimental visceral leishmaniasis in interferon γ gene disrupted mice. J. Exp. Med. 185, 1231-1239.
33. BAKHIET, M., OLSSON, T., MHLANGA, J., BÜSCHER, P., LYCKE, N., VAN DER MEIDE, P.H., and KRISTENSSON, K. (1996). Human and rodent IFNγ as a growth factor for Trypanosoma brucei. Eur. J. Immunol. 26, 1359-1364.
34. AMIRI, P., HAAK-FRENDSCHO, M., ROBBINS, K., MCKERROW, J.H., STEWART, T., and JARDIEU, P. (1994). Anti-immunoglobulin E treatment decreases worm burden and egg production in Schistosoma manjoni-infected normal and interferon γ knock-out mice. J. Exp. Med. 180, 43-51.
35. TSUJI, M., MIYAHIRA, Y., NUSSENZWEIG, R.S., AGUET, M., REICHEL, M., and ZAVALA, F. (1995). Development of anti-malarial immunity in mice lacking IFNγ receptor. J. Immunol. 154, 5338-5344.
36. RUDIN, W., FAVRE, N., BORDMANN, G., and RYFFEL, B. (1997). Interferon γ is essential for the development of cerebral malaria. Eur. J. Immunol. 27, 810-815.
37. VAN DEN BROEK, M.F., MÜLLER, U., HUANG, S., ZINKERNAGEL, R.M., and AGUET, M. (1995). Immune defence in mice lacking type I and/or type II interferon receptors. Immunol. Rev. 148, 5-19.
38. MURRAY, H.W. (1994). Interferon γ and host antimicrobial defense: current and future clinical applications. Am. J. Med. 97, 459-467.